425 related articles for article (PubMed ID: 8940339)
1. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
[TBL] [Abstract][Full Text] [Related]
2. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP.
Wang QF; Tilly KI; Tilly JL; Preffer F; Schneyer AL; Crowley WF; Sluss PM
Endocrinology; 1996 Dec; 137(12):5476-83. PubMed ID: 8940374
[TBL] [Abstract][Full Text] [Related]
3. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.
Fujii Y; Kawakami S; Okada Y; Kageyama Y; Kihara K
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E927-31. PubMed ID: 14761877
[TBL] [Abstract][Full Text] [Related]
4. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
5. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin.
Dalkin AC; Haisenleder DJ; Yasin M; Gilrain JT; Marshall JC
Endocrinology; 1996 Feb; 137(2):548-54. PubMed ID: 8593801
[TBL] [Abstract][Full Text] [Related]
6. Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer.
Thomas TZ; Wang H; Niclasen P; O'Bryan MK; Evans LW; Groome NP; Pedersen J; Risbridger GP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3851-8. PubMed ID: 9360551
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145.
McPherson SJ; Thomas TZ; Wang H; Gurusinghe CJ; Risbridger GP
J Endocrinol; 1997 Sep; 154(3):535-45. PubMed ID: 9379131
[TBL] [Abstract][Full Text] [Related]
8. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.
van Schaik RH; Wierikx CD; Timmerman MA; Oomen MH; van Weerden WM; van der Kwast TH; van Steenbrugge GJ; de Jong FH
Br J Cancer; 2000 Jan; 82(1):112-7. PubMed ID: 10638976
[TBL] [Abstract][Full Text] [Related]
9. Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells.
Di Simone N; Hall HA; Welt C; Schneyer AL
Endocrinology; 1998 Mar; 139(3):1147-55. PubMed ID: 9492049
[TBL] [Abstract][Full Text] [Related]
10. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells.
Bilezikjian LM; Corrigan AZ; Blount AL; Chen Y; Vale WW
Endocrinology; 2001 Mar; 142(3):1065-72. PubMed ID: 11181520
[TBL] [Abstract][Full Text] [Related]
11. Sex difference in the action of activin-A on cell proliferation of differentiating rat gonad.
Kaipia A; Toppari J; Huhtaniemi I; Paranko J
Endocrinology; 1994 May; 134(5):2165-70. PubMed ID: 8156918
[TBL] [Abstract][Full Text] [Related]
12. Expression of activin A and follistatin core proteins by human prostate tumor cell lines.
McPherson SJ; Mellor SL; Wang H; Evans LW; Groome NP; Risbridger GP
Endocrinology; 1999 Nov; 140(11):5303-9. PubMed ID: 10537161
[TBL] [Abstract][Full Text] [Related]
13. Regulation of prostate branching morphogenesis by activin A and follistatin.
Cancilla B; Jarred RA; Wang H; Mellor SL; Cunha GR; Risbridger GP
Dev Biol; 2001 Sep; 237(1):145-58. PubMed ID: 11518512
[TBL] [Abstract][Full Text] [Related]
14. Activin A stimulates AKR1C3 expression and growth in human prostate cancer.
Hofland J; van Weerden WM; Steenbergen J; Dits NF; Jenster G; de Jong FH
Endocrinology; 2012 Dec; 153(12):5726-34. PubMed ID: 23024260
[TBL] [Abstract][Full Text] [Related]
15. Identification of an activin-follistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells.
Wang Q; Tabatabaei S; Planz B; Lin CW; Sluss PM
J Urol; 1999 Apr; 161(4):1378-84. PubMed ID: 10081911
[TBL] [Abstract][Full Text] [Related]
16. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
[TBL] [Abstract][Full Text] [Related]
17. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP.
Zhang Z; Zhao Y; Batres Y; Lin MF; Ying SY
Biochem Biophys Res Commun; 1997 May; 234(2):362-5. PubMed ID: 9177276
[TBL] [Abstract][Full Text] [Related]
18. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors.
Bilezikjian LM; Corrigan AZ; Blount AL; Vale WW
Endocrinology; 1996 Oct; 137(10):4277-84. PubMed ID: 8828487
[TBL] [Abstract][Full Text] [Related]
19. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin.
Delbaere A; Sidis Y; Schneyer AL
Endocrinology; 1999 Jun; 140(6):2463-70. PubMed ID: 10342830
[TBL] [Abstract][Full Text] [Related]
20. Inhibins, activins, and follistatins: expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia.
Thomas TZ; Chapman SM; Hong W; Gurusingfhe C; Mellor SL; Fletcher R; Pedersen J; Risbridger GP
Prostate; 1998 Jan; 34(1):34-43. PubMed ID: 9428386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
